Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis.

Expert opinion on emerging drugs - 1 Jun 2018

Aryal Shambhu, Nathan Steven D

Abstract excerpt

INTRODUCTION: Idiopathic pulmonary fibrosis is a chronic, progressive fibrotic lung disease of unknown etiology associated with a high morbidity and mortality. The hallmark of the disease is impaired healing after alveolar epithelial injury in the setting of a genetic predisposition. Development of two new drugs has changed the landscape of the treatment of IPF but more work is needed to improve outcomes and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Disease Progression
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Idiopathic Pulmonary Fibrosis

Share to Indoles

Share to Pyridones

Source

Identifiers

PMID: 29718783
DOI: 10.1080/14728214.2018.1471465

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis.PMID 29718783Read ↗

Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis.Semantic proximity Read ↗

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary FibrosisSemantic proximity Read ↗

A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy.Semantic proximity Read ↗

Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies.Semantic proximity Read ↗

Recent advances in understanding idiopathic pulmonary fibrosisSemantic proximity Read ↗

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.Semantic proximity Read ↗

Novel mechanisms and treatment of idiopathic pulmonary fibrosis.Semantic proximity Read ↗

Immunological mechanisms and therapeutic approaches in pulmonary fibrosis.Semantic proximity Read ↗

Regulation of idiopathic pulmonary fibrosis: a cross-talk between TGF-β signaling and MicroRNAsSemantic proximity Read ↗

Building translational bridges in idiopathic pulmonary fibrosis research: from epithelial dysfunction to dysregulated macrophage polarisation and fibrogenesisSemantic proximity Read ↗

[How i treat a patient with idiopathic pulmonary fibrosis].Semantic proximity Read ↗

Inhibition of fibrosis with multi-agent therapy in pulmonary fibrosis: Results of a drug library screeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.